Richard E. Pratley MD
Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute, Orlando, Florida; Medical Director, AdventHealth Diabetes Institute, Orlando, Florida; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MarylandDr. Richard Pratley, an internationally recognized expert in diabetes, is Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute and Medical Director of the AdventHealth Diabetes Institute in Orlando, as well as Adjunct Professor of Medicine, Johns Hopkins University School of Medicine.
Dr. Pratley is a principal investigator for both NIH- and pharmaceutical company–sponsored trials in diabetes and obesity. His current research interests include the prevention of diabetes, improving the care of older individuals with diabetes, developing new drugs to treat and prevent diabetes and its complications, understanding the role of the fat cell in increasing the risk for diabetes and heart disease, and investigating extracellular vesicles in inter-cellular and inter-organ cross-talk. He presents his research regularly at national and international meetings and has written over 300 peer-reviewed articles. He is a member of the American Diabetes Association and the European Association for the Study of Diabetes. He has served on the editorial boards of a number of high impact journals, including Diabetes Care, The Lancet Diabetes and Endocrinology, The Journal of Clinical Endocrinology & Metabolism, and the Journal of Diabetes and Its Complications.
After receiving his medical degree from Wayne State University in Detroit and undergoing residency training in internal medicine the University of Michigan in Ann Arbor, he completed fellowships in geriatric medicine and gerontology at the University of Michigan, Johns Hopkins University, and the National Institute on Aging.
Positions:
Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute; Medical Director, AdventHealth Diabetes Institute; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine
Degrees:
MD: Wayne State University, Detroit, Michigan
Postgraduate Training:
Fellowship (geriatric medicine and gerontology): University of Michigan, Johns Hopkins University, National Institute on Aging
Research Interests:
Prevention of diabetes; improving the care of older individuals with diabetes; developing new drugs to treat and prevent diabetes and its complications; understanding the role of the fat cell in increasing the risk for diabetes and heart disease; investigating extracellular vesicles in inter-cellular and inter-organ cross-talk.
Disclosures
Dr. Pratley has received the following (directed to his institution): speaker fees from Merck and Novo Nordisk; consulting fees from Bayer AG, Endogenex, Inc., Gasherbrum Bio, Inc., Hengrui (USA) Ltd., Intas Pharmaceuticals, Inc., Lilly, Novo Nordisk, Pfizer, Rivus Pharmaceuticals Inc., and Sun Pharmaceutical Industries; and grants from Dompe and Novo Nordisk.
Recent Contributions to PracticeUpdate:
- ADA Scientific Sessions 2017: Recommendations From Dr. Richard Pratley
- Efficacy and Safety of Incretin-Based Drugs in Patients With Type 1 Diabetes Mellitus
- 2016 Top Stories in Diabetes: A Resurgence of Interest in Pioglitazone?
- Altered Glucose Metabolism Found in Pregnancy After Gastric Bypass
- The Advance of the Artificial Pancreas
- Closing the Loop: Drs. Silvio Inzucchi and Richard Pratley Talk About the Advance of the Artificial Pancreas
- LixiLan Decreases HbA1c Levels and Body Weight in Diabetic Patients
- FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM
- Exenatide Demonstrates Improvement In Glycemic Control and Body Weight for Diabetic Patients
- Dapagliflozin Added to Liraglutide and Insulin Improves Glycemia and Weight Loss in Type 1 Diabetes